Navigation Links
Notal Vision's ForeseeHome(TM) AMD Monitor Receives FDA Clearance
Date:1/27/2010

ST. LOUIS, Jan. 27 /PRNewswire/ -- Notal Vision's ForeseeHome™ AMD Monitor has received Section 510 (k) clearance from the U.S. Food and Drug Administration (FDA).

The ForeseeHome AMD Monitor is the first ophthalmic device linking patients and doctors between eye exams for ongoing monitoring of age-related macular degeneration (AMD).  Patients complete a frequent but brief exam on their ForeseeHome AMD Monitor, in the comfort of their own home, and data is transmitted to the patients' eye care physician and the Notal Vision Data Monitoring Center.  The award winning ergonomic design of the ForeseeHome AMD Monitor is comfortable and easy to use for patients at risk of vision loss from wet AMD.

Wet AMD is the leading cause of blindness in people over the age of 60 in the western world.  Recent breakthroughs in treatments place even greater importance on early detection, which can reduce the risks of vision loss associated with wet AMD.  Frequent monitoring is critical in detecting disease onset as early as possible and the ForeseeHome AMD Monitor is the first home monitoring device for following patients at risk of vision loss, offering hope for early intervention through early detection.

Numerous clinical studies have demonstrated the ForeseeHome AMD Monitor is an accurate and reliable tool for frequent monitoring of patients at risk for vision loss from wet AMD.

For more information, please visit www.notalvision.com.

Notal Vision was founded by a team of medical professionals determined to develop better methods of AMD monitoring and reduce vision loss associated with AMD. Notal Vision's corporate headquarters are located in Tel Aviv, Israel, with U.S. headquarters and a distribution center in St. Louis, MO.

SOURCE Notal Vision

RELATED LINKS
http://www.notalvision.com

'/>"/>

SOURCE Notal Vision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vivakor Divisions Continue to Demonstrate Independent Growth
2. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
3. Microlifes Home Blood Pressure Monitors Proven Accurate Even for Critical Patients
4. ACC Concerned Over Reporting of Biomonitoring Results
5. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
6. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
7. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
8. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
9. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
10. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
11. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... SCOTTSDALE, Ariz. , Jan. 17, 2017 ... retired US Navy Capt. Mark Kelly as ... (ACMA) 2017 National Conference in Washington D.C. ... shuttle commander, will speak on Friday morning, April 21 ... management professionals from across the country are expected to ...
(Date:1/17/2017)... Jan. 17, 2017  Market Research Future published a Half Cooked ... is expected to reach USD 33.6 million during the period 2016 ... Highlights ... Endoscopy Devices Market has been examined as a swiftly growing market ... huge demand for endoscopy device in various regions.  The increasing growth ...
(Date:1/17/2017)... NEW YORK , Jan. 17, 2016  Attorney Advertising ... on behalf of purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or ... encouraged to obtain additional information and assist the investigation by ... investigation concerns whether Anthera and certain of its officers and/or ... Exchange Act of 1934. ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress – ... to choose the best drug option for each patient. Dentists have several general anesthesia ... overall outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted to ...
(Date:1/17/2017)... AZ (PRWEB) , ... January 17, 2017 , ... ... and improved supplement, Healthful-Flex. , The company, owned and operated by Ed ... public at a reasonable price with the highest level of customer service. Healthful ...
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve TMS West, with ... a new office in San Clemente, California this month. Achieve TMS West is ... successfully treating individuals struggling with major depression. Depression impacts over 15 million adults ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... A ... named winners of the fourth Cradle to Cradle Product Design Challenge , the ... fourth in a series of six circular design challenges scheduled to run through early ...
(Date:1/17/2017)... Gatos, CA (PRWEB) , ... January 17, 2017 , ... ... announced the results of a double blind clinical study for its dental gel that ... a leading national brand of toothpaste containing triclosan. The study was conducted at the ...
Breaking Medicine News(10 mins):